{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T02:13:59Z","timestamp":1712801639348},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,10]]},"DOI":"10.7759\/cureus.57994","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T01:42:01Z","timestamp":1712799721000},"source":"Crossref","is-referenced-by-count":0,"title":["Uncommon Manifestation: Thrombotic Thrombocytopenic Purpura Presenting Solely as Petechial Rash"],"prefix":"10.7759","author":[{"given":"Faryal","family":"Altaf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shitij","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachana","family":"Allena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misbahuddin","family":"Khaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly BS","year":"2017","unstructured":"Joly BS, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017, 129:2836-46. 10.1182\/blood-2016-10-709857","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-061813-013241","article-title":"ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura","volume":"66","author":"Zheng XL","year":"2015","unstructured":"Zheng XL. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu Rev Med. 2015, 66:211-25. 10.1146\/annurev-med-061813-013241","journal-title":"Annu Rev Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030536","article-title":"Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management","volume":"10","author":"Sukumar S","year":"2021","unstructured":"Sukumar S, L\u00e4mmle B, Cataland SR. Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management. J Clin Med. 2021, 10:10.3390\/jcm10030536","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3402\/jchimp.v6.32258","article-title":"An improbable and unusual case of thrombotic thrombocytopenia purpura","volume":"6","author":"Patel J","year":"2016","unstructured":"Patel J, Patel P, Ahmed Z. An improbable and unusual case of thrombotic thrombocytopenia purpura. J Community Hosp Intern Med Perspect. 2016, 6:32258. 10.3402\/jchimp.v6.32258","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18502\/ijhoscr.v14i3.3724","article-title":"Atypical presentation of thrombotic thrombocytopenic purpura without hematological features","volume":"14","author":"Singh B","year":"2020","unstructured":"Singh B, Chan KH, Kaur P, Modi V, Maroules M. Atypical presentation of thrombotic thrombocytopenic purpura without hematological features. Int J Hematol Oncol Stem Cell Res. 2020, 14:167-70. 10.18502\/ijhoscr.v14i3.3724","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3519937","article-title":"The efficacy and safety of plasma exchange in the treatment of thrombotic thrombocytopenic purpura","volume":"2022","author":"Pan Z","year":"2022","unstructured":"Pan Z, Zhang Z, Yang Y, Hao W. The efficacy and safety of plasma exchange in the treatment of thrombotic thrombocytopenic purpura. J Healthc Eng. 2022, 2022:3519937. 10.1155\/2022\/3519937","journal-title":"J Healthc Eng"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23126","article-title":"Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura","volume":"87 Suppl 1","author":"George JN","year":"2012","unstructured":"George JN. Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura. Am J Hematol. 2012, 87 Suppl 1:S88-91. 10.1002\/ajh.23126","journal-title":"Am J Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-551580","article-title":"How I treat refractory thrombotic thrombocytopenic purpura","volume":"125","author":"Sayani FA","year":"2015","unstructured":"Sayani FA, Abrams CS. How I treat refractory thrombotic thrombocytopenic purpura. Blood. 2015, 125:3860-7. 10.1182\/blood-2014-11-551580","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20182","article-title":"Atypical presentations of thrombotic thrombocytopenic purpura: a review","volume":"24","author":"Sarode R","year":"2009","unstructured":"Sarode R. Atypical presentations of thrombotic thrombocytopenic purpura: a review. J Clin Apher. 2009, 24:47-52. 10.1002\/jca.20182","journal-title":"J Clin Apher"},{"key":"ref10","article-title":"Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes","volume":"2012","author":"George JN","year":"2012","unstructured":"George JN, Al-Nouri ZL. Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes. Hematology Am Soc Hematol Educ Program. 2012, 2012:604-9.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-016-1342-7","article-title":"Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13","volume":"42","author":"Kalish Y","year":"2016","unstructured":"Kalish Y, Rottenstreich A, Rund D, Hochberg-Klein S. Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13. J Thromb Thrombolysis. 2016, 42:155-60. 10.1007\/s11239-016-1342-7","journal-title":"J Thromb Thrombolysis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2021.07.045","article-title":"Evaluation and management of thrombotic thrombocytopenic purpura in the emergency department","volume":"61","author":"Long B","year":"2021","unstructured":"Long B, Bridwell RE, Manchanda S, Gottlieb M. Evaluation and management of thrombotic thrombocytopenic purpura in the emergency department. J Emerg Med. 2021, 61:674-82. 10.1016\/j.jemermed.2021.07.045","journal-title":"J Emerg Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.62.1222","article-title":"Treatment strategy for patients with thrombotic thrombocytopenic purpura [Article in Japanese]","volume":"62","author":"Yagi H","year":"2021","unstructured":"Yagi H. Treatment strategy for patients with thrombotic thrombocytopenic purpura [Article in Japanese] . Rinsho Ketsueki. 2021, 62:1222-8. 10.11406\/rinketsu.62.1222","journal-title":"Rinsho Ketsueki"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Kremer Hovinga JA","year":"2010","unstructured":"Kremer Hovinga JA, Vesely SK, Terrell DR, L\u00e4mmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010, 115:1500-11; quiz 1662. 10.1182\/blood-2009-09-243790","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2020.103011","article-title":"Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunoglobulins (CASPERI)","volume":"60","author":"Cid J","year":"2021","unstructured":"Cid J, P\u00e9rez-Valencia AI, Torrente M\u00c1, \u00c1varez-Larr\u00e1n A, D\u00edaz-Ricart M, Esteve J, Lozano M. Successful management of three patients with autoimmune thrombotic thrombocytopenic purpura with paradigm-changing therapy: caplacizumab, steroids, plasma exchange, rituximab, and intravenous immunoglobulins (CASPERI). Transfus Apher Sci. 2021, 60:103011. 10.1016\/j.transci.2020.103011","journal-title":"Transfus Apher Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15093","article-title":"Maintenance rituximab for relapsing thrombotic thrombocytopenic purpura: a case report","volume":"59","author":"Saleem R","year":"2019","unstructured":"Saleem R, Rogers ZR, Neunert C, George JN. Maintenance rituximab for relapsing thrombotic thrombocytopenic purpura: a case report. Transfusion. 2019, 59:921-6. 10.1111\/trf.15093","journal-title":"Transfusion"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0300060517695646","article-title":"Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura","volume":"45","author":"Chen H","year":"2017","unstructured":"Chen H, Fu A, Wang J, et al.. Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura. J Int Med Res. 2017, 45:1253-60. 10.1177\/0300060517695646","journal-title":"J Int Med Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12114","article-title":"Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse","volume":"11","author":"Westwood JP","year":"2013","unstructured":"Westwood JP, Webster H, McGuckin S, McDonald V, Machin SJ, Scully M. Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse. J Thromb Haemost. 2013, 11:481-90. 10.1111\/jth.12114","journal-title":"J Thromb Haemost"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-496752","article-title":"Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura","volume":"122","author":"Deford CC","year":"2013","unstructured":"Deford CC, Reese JA, Schwartz LH, et al.. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood. 2013, 122:2023-9; quiz 2142. 10.1182\/blood-2013-04-496752","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5045\/br.2022.2022005","article-title":"Recent advances in the management of immune-mediated thrombotic thrombocytopenic purpura","volume":"57","author":"Bae SH","year":"2022","unstructured":"Bae SH, Kim SH, Bang SM. Recent advances in the management of immune-mediated thrombotic thrombocytopenic purpura. Blood Res. 2022, 57:37-43. 10.5045\/br.2022.2022005","journal-title":"Blood Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/245066-uncommon-manifestation-thrombotic-thrombocytopenic-purpura-presenting-solely-as-petechial-rash","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T01:42:07Z","timestamp":1712799727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/245066-uncommon-manifestation-thrombotic-thrombocytopenic-purpura-presenting-solely-as-petechial-rash"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.57994","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,10]]}}}